{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-003414","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.805280+00:00","generated_at":"2026-06-04T17:18:10.954078+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Helius Medical amends bylaws: quorum cut to one-third, universal proxy rules adopted","bullets":["Quorum requirement reduced from majority to one-third of voting power for stockholder meetings.","Universal proxy rules adopted per SEC Rule 14a-19; only Board nominees allowed unless complying.","Enhanced disclosure for stockholder director nominations and proposals; board may request additional info.","Special meeting nomination requires 10% voting power; stockholder status at notice and record date.","Technical and clarifying changes to reflect updates in Delaware General Corporation Law."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-003414","json":"https://secwatch.observer/filing/0001558370-24-003414.json","markdown":"https://secwatch.observer/filing/0001558370-24-003414.md","text":"https://secwatch.observer/filing/0001558370-24-003414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/0001558370-24-003414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/hsdt-20240312x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T17:18:10.954078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec97c9b7f3379cb52e667da68b1eb9d2a23896c5","claim":"Solana Co: Amended and restated bylaws to reduce stockholder meeting quorum, address universal proxy rules, update disclosure requirements, impose new special meeting nomination conditions, and clarify personal jurisdiction (effective 2024-03-12).","evidence_excerpt":"On March 12, 2024, the Board of Directors (the “ Board ”) of Helius Medical Technologies, Inc., a Delaware corporation (the “ Company ”) approved and adopted the Company’s Second Amended and Restated Bylaws (the “ Second Amended and Restated Bylaws ”), which became effective the same day.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024003414/0001558370-24-003414-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-03-12"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}